Rob Badman

1 week ago | stockhead.com.au | Rob Badman |Phoebe Shields

Stockhead is providing factual information where there is a reasonable likelihood of doubt. The information is not intended to imply any recommendation or opinion about a financial product. A NOTE ABOUT RELEVANT ADVERTISING We collect information about the content (including ads) you use across this site and use it to make both advertising and content more relevant to you on our network and other sites.

2 weeks ago | stockhead.com.au | Rob Badman

Stockhead’s monthly crypto wrap, Mooners and Shakers, is brought to you by We’re not going to sugarcoat it, the crypto market is in the gutter right now. Thanks, DonaldThen again… it’s hardly the lone ranger among Trump-roiled markets and sectors, is itIn fact, let’s sugar it after all… there are some silver linings to be found.

2 weeks ago | stockhead.com.au | Rob Badman

Stockhead has been undergoing a bit of a transformation of late. And you can see a good deal of that manifested in the brand, spanking new website you’re currently viewing. Along with “clean, modern lines”, a faster, improved navigational experience and a much stronger focus on video and features content, we’ve reconstructed the site keeping Stockhead’s DNA very much intact. Consider it an upgrade if not a total revamp.

3 weeks ago | stockhead.com.au | Rob Badman

Nanosonics (ASX:NAN) chief Michael Kavanagh says he’s “very proud” of the device maker’s ability to win US Food and Drug Administration (FDA) approval for its second medical probe sterilisation device, Coris. He’s chuffed just not just by the assent, but because the device was approved under the more difficult de novo (new device) pathway. Overwhelmingly, the FDA has approved devices under the 510(k) existing (predicate) device route.

3 weeks ago | stockhead.com.au | Rob Badman

In the arvo session, the ASX held on to early gains… by a threadNervy investor/trader eyes now await updates from the US on yet more inflation data and tariff announcementsAmid the turmoil, wouldn’t you know it, gold stole the show After chugging along without too much drama this morning, the ASX was the Little Bourse that Could this arvo, getting over a hump and eventually carrying its stocks to a +0.16 win. Not as good as it was potentially looking at lunch but a better result than yesterday.